AC
Abraham Ceesay (Chief Executive Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $2.4M of RAPP (51,499 sh across 5 lots, as filed), executed Aug 10. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.8M
shares × price, as filed
Last traded
Oct 6
Filed Oct 8
Median ADV $17.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
RAPPRecent filings
RAPPSALE
Rapport Therapeutics, Inc.
View filing →
$231K8,975 sh across 2 lots
Exec Oct 15 2025
Filed Oct 16 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $2.0M
74,320 sh across 2 lots
Exec Sep 17 2025
Filed Sep 19 2025 · 5:30 PM ET